ZEB1 and c-Jun Levels Contribute to the Establishment of Highly Lytic Epstein-Barr Virus Infection in Gastric AGS Cells
- 15 September 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (18) , 10113-10122
- https://doi.org/10.1128/jvi.00692-07
Abstract
The induction of lytic infection has been proposed as a therapeutic strategy for treating Epstein-Barr virus (EBV)-positive malignancies. To succeed, efficient methods are needed for activating the EBV immediate-early (IE) promoters, Zp and Rp. Here we compared factors which regulate Zp and Rp in AGS gastric carcinoma cells that support a remarkably high level of persistently lytic EBV infection with HeLa cervical cells that permit only tightly latent infection. We found that the level of Zp activity assayed by transient transfection assays with reporter plasmids was high in AGS cells but low in HeLa cells. The level of Rp activity was low in both cell types. Mutational analysis indicated that sequences within Zp located between -70 and +27 relative to the transcription initiation site were sufficient to confer a high level of Zp activity in AGS cells. The Zp CRE motif was necessary for this constitutive activity, while the ZIA and ZIB MEF2D motifs were not. Consistent with these findings, immunoblot analysis indicated that phosphorylated c-Jun, which activates Zp through the CRE motif, was expressed at a much higher level in EBV-infected AGS cells than in EBV-infected HeLa cells. In contrast, ZEB1, which represses Zp via the ZV motif located near the transcription initiation site, was abundant in HeLa cells, while it was absent from AGS cells. Exogenous addition of ZEB1 led to the repression of Zp in AGS cells. We conclude that the unusually high Zp activity level in AGS cells is due to the high abundance of positively acting transcription factors such as c-Jun combined with the low abundance of negatively acting factors such as ZEB1.Keywords
This publication has 92 references indexed in Scilit:
- Epstein-Barr Virus Lytic Infection Induces Retinoic Acid-responsive Genes through Induction of a Retinol-metabolizing Enzyme, DHRS9Published by Elsevier ,2007
- Valproic Acid Enhances the Efficacy of Chemotherapy in EBV-Positive Tumors by Increasing Lytic Viral Gene ExpressionCancer Research, 2006
- Contribution of C/EBP Proteins to Epstein-Barr Virus Lytic Gene Expression and Replication in Epithelial CellsJournal of Virology, 2006
- Association with Class IIa Histone Deacetylases Upregulates the Sumoylation of MEF2 Transcription FactorsMolecular and Cellular Biology, 2005
- ZEB Negatively Regulates the Lytic-Switch BZLF1 Gene Promoter of Epstein-Barr VirusJournal of Virology, 2003
- Epstein–Barr virus post‐transplant lymphoproliferative disease and virus‐specific therapy: pharmacological re‐activation of viral target genes with arginine butyrateTransplant Infectious Disease, 2001
- Identification of a Novel Element Involved in Regulation of the Lytic Switch BZLF1 Gene Promoter of Epstein-Barr VirusJournal of Virology, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Epstein–Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinomaSeminars in Cancer Biology, 1996
- Epstein–Barr Virus Replication in Oropharyngeal Epithelial CellsNew England Journal of Medicine, 1984